MEK1/2 inhibition decreases pro-inflammatory responses in macrophages from people with cystic fibrosis and mitigates severity of illness in experimental murine methicillin-resistant Staphylococcus aureus infection
M. De, K. B. Hisert, W. C. Liles, A. M. Manicone, E. A. Hemann, M. E. Long
This study shows MEK1/2 inhibitors reduce inflammation in CF macrophages and improve outcomes in MRSA-infected mice without affecting pathogen clearance.
bioRxiv · Jan 22, 2023 · PreprintImmunology